InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Lebwohl David, Vice-Président Exécutif et Responsable Médical. Officer active across 1 companies, notably Intellia Therapeutics, Inc.. Aggregated, 13 disclosures have been recorded. The latest transaction was disclosed on 5 November 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations13 total
3,187 shares
Common Stock
SEC:0001209191-22-015960:0·
€26,2112,400 shares@ €10.92130.0014% mcap12.2% of flow
Common Stock
SEC:0001209191-21-063698·
€26,2112,400 shares@ €10.92130.0014% mcap6.1% of flow
Common Stock
SEC:0001209191-21-063698:0·
€26,1292,400 shares@ €10.88730.0014% mcap12.2% of flow
Common Stock
SEC:0001209191-21-060638·
€26,1292,400 shares@ €10.88730.0014% mcap6.1% of flow
Common Stock
SEC:0001209191-21-060638:0·
€85,1677,923 shares@ €10.74930.0045% mcap39.6% of flow
Common Stock
SEC:0001209191-21-057778·
€85,1677,923 shares@ €10.74930.0045% mcap19.8% of flow
Common Stock
SEC:0001209191-21-057778:0·
€25,8372,400 shares@ €10.76520.0014% mcap12.0% of flow
Common Stock
SEC:0001209191-21-057475·
€25,8372,400 shares@ €10.76520.0014% mcap6.0% of flow
Common Stock
SEC:0001209191-21-057475:0·
€25,6752,400 shares@ €10.69770.0013% mcap12.0% of flow
Common Stock
SEC:0001209191-21-054317·
€25,6752,400 shares@ €10.69770.0013% mcap6.0% of flow
Common Stock
SEC:0001209191-21-054317:0·
€25,8022,400 shares@ €10.7510.0014% mcap12.0% of flow
Common Stock
SEC:0001209191-21-050881·
€25,8022,400 shares@ €10.7510.0014% mcap6.0% of flow
Common Stock
SEC:0001209191-21-050881:0·
13 of 13 declarations
About Lebwohl David
Lebwohl David serves as Executive Vice President and Chief Medical Officer at Intellia Therapeutics, Inc. He oversees the company's medical and research strategies, ensuring innovation and advancement of health objectives. His role is crucial in the development of new treatments.
